176,401 Shares in Liquidia Corporation $LQDA Bought by T3 Companies LLC

T3 Companies LLC acquired a new stake in Liquidia Corporation (NASDAQ:LQDA) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 176,401 shares of the company’s stock, valued at approximately $6,084,000. Liquidia makes up approximately 7.6% of T3 Companies LLC’s holdings, making the stock its 3rd largest position. T3 Companies LLC owned about 0.20% of Liquidia at the end of the most recent quarter.

A number of other large investors have also modified their holdings of LQDA. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Liquidia during the 4th quarter worth about $25,000. NewEdge Advisors LLC purchased a new position in shares of Liquidia in the 2nd quarter valued at about $25,000. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Liquidia in the 3rd quarter valued at about $30,000. FNY Investment Advisers LLC acquired a new position in Liquidia in the 3rd quarter worth about $34,000. Finally, Covestor Ltd raised its holdings in Liquidia by 41.9% in the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after purchasing an additional 359 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on LQDA shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a research report on Tuesday, April 21st. Wall Street Zen raised Liquidia from a “buy” rating to a “strong-buy” rating in a research note on Saturday, May 16th. Lifesci Capital upgraded Liquidia to a “strong-buy” rating in a research report on Thursday, March 5th. Zacks Research raised shares of Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Finally, Raymond James Financial reissued a “strong-buy” rating and issued a $68.00 price target on shares of Liquidia in a report on Thursday, June 4th. Three equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Liquidia has an average rating of “Moderate Buy” and a consensus price target of $60.29.

Liquidia Price Performance

NASDAQ:LQDA opened at $65.25 on Thursday. Liquidia Corporation has a one year low of $11.85 and a one year high of $66.78. The stock has a market cap of $5.80 billion, a PE ratio of 466.10 and a beta of 0.58. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22. The stock has a 50 day moving average price of $48.50 and a 200 day moving average price of $40.37.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. The company had revenue of $132.87 million for the quarter, compared to analyst estimates of $119.44 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The business’s revenue for the quarter was up 4187.1% compared to the same quarter last year. Equities research analysts expect that Liquidia Corporation will post 2.97 EPS for the current fiscal year.

Insider Buying and Selling at Liquidia

In other news, Director Raman Singh sold 29,494 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $60.13, for a total transaction of $1,773,474.22. Following the transaction, the director owned 38,755 shares of the company’s stock, valued at approximately $2,330,338.15. The trade was a 43.22% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Roger Jeffs sold 32,744 shares of the company’s stock in a transaction dated Monday, April 13th. The shares were sold at an average price of $38.37, for a total transaction of $1,256,387.28. Following the completion of the sale, the chief executive officer directly owned 1,137,599 shares of the company’s stock, valued at $43,649,673.63. This represents a 2.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 1,673,680 shares of company stock worth $85,949,087. Corporate insiders own 25.60% of the company’s stock.

Liquidia Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).